Cargando…

Copy number gain of ACTN4 is associated with poor prognosis in patients with upper urinary tract urothelial carcinoma

α‐Actinin4 (ACTN4), an isoform of non‐muscular α‐actinin, is involved in enhancing cell motility and promoting cancer infiltration and metastasis in various cancers. However, information remains limited regarding the pathological significance of ACTN4 expression in upper urinary tract urothelial car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawamura, Kazuki, Miyai, Kosuke, Sato, Kimiya, Matsukuma, Susumu, Honda, Kazufumi, Ito, Keiichi, Tsuda, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394141/ https://www.ncbi.nlm.nih.gov/pubmed/37226638 http://dx.doi.org/10.1111/cas.15841

Ejemplares similares

Prognostic impact of stromal periostin expression in upper urinary tract urothelial carcinoma
por: Miyai, Kosuke, et al.
Publicado: (2022)

Copy number increase of ACTN4 is a prognostic indicator in salivary gland carcinoma
por: Watabe, Yukio, et al.
Publicado: (2014)

Prognostic impact of ACTN4 gene copy number alteration in hormone receptor-positive, HER2-negative, node-negative invasive breast carcinoma
por: Sugano, Teppei, et al.
Publicado: (2020)

Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages
por: Kono-Sato, Takako, et al.
Publicado: (2022)

Acquired Cystic Disease-Associated Renal Cell Carcinoma Extending to the Renal Pelvis Mimicking Urothelial Carcinoma on Computed Tomography (CT): Two Case Reports
por: Edo, Hiromi, et al.
Publicado: (2020)

Clinically undetected plasmacytoid urothelial carcinoma of the urinary bladder with non-mass-forming metastases in multiple organs: an autopsy case
por: Asano, Yuya, et al.
Publicado: (2022)

The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer
por: Honda, Kazufumi
Publicado: (2015)

Chronic lymphocytic leukemia and concurrent seminoma in the same testis
por: Miyai, Kosuke, et al.
Publicado: (2022)

ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer
por: Watanabe, T, et al.
Publicado: (2015)

Copy Number Signatures and Clinical Outcomes in Upper Tract Urothelial Carcinoma
por: Guan, Bao, et al.
Publicado: (2021)

Prostate cancer recurrence mimicking invasive urothelial cancer of the bladder
por: Okubo, Kazuki, et al.
Publicado: (2020)

Change of guard at ACTN
por: Hoke, Ahmet
Publicado: (2023)

Clinical impacts of genomic copy number gains at Xq28
por: Yamamoto, Toshiyuki, et al.
Publicado: (2014)

Benefits from Adjuvant Chemotherapy in Patients with Resected Non-Small Cell Lung Cancer: Possibility of Stratification by Gene Amplification of ACTN4 According to Evaluation of Metastatic Ability
por: Tozuka, Takehiro, et al.
Publicado: (2022)

DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors
por: Bambury, Richard M, et al.
Publicado: (2015)

Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations
por: Nishiyama, Naotaka, et al.
Publicado: (2011)

Rapid progression of mucinous tubular and spindle cell carcinoma of the kidney without sarcomatoid changes: A case report
por: Isono, Makoto, et al.
Publicado: (2020)

Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4
por: Miura, Nami, et al.
Publicado: (2016)

Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC
por: Zito Marino, Federica, et al.
Publicado: (2020)

Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas
por: Seo, A N, et al.
Publicado: (2014)

Centromere 17 copy number gain reflects chromosomal instability in breast cancer
por: Lee, Kyoungyul, et al.
Publicado: (2019)

High Expression Levels of ACTN1 and ACTN3 Indicate Unfavorable Prognosis in Acute Myeloid Leukemia
por: Yang, Xinrui, et al.
Publicado: (2019)

DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma
por: Conconi, Donatella, et al.
Publicado: (2012)

ACTN3, Morbidity, and Healthy Aging
por: Pickering, Craig, et al.
Publicado: (2018)

Mutation update for the ACTN2 gene
por: Ranta‐aho, Johanna, et al.
Publicado: (2022)

Copy number gain of VCX, X-linked multi-copy gene, leads to cell proliferation and apoptosis during spermatogenesis
por: Ji, Juan, et al.
Publicado: (2016)

Alpha‐actinin‐4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas
por: Noro, Rintaro, et al.
Publicado: (2022)

Somatic mutation and gain of copy number of PIK3CA in human breast cancer
por: Wu, Guojun, et al.
Publicado: (2005)

c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer
por: Lee, Kyu Sang, et al.
Publicado: (2015)

The prognostic significance of MCL1 copy number gain in esophageal squamous cell carcinoma
por: Xu, Chen, et al.
Publicado: (2017)

Composite pheochromocytoma–ganglioneuroma: a case with two distinct components radiographically
por: Edo, Hiromi, et al.
Publicado: (2022)

Comprehensive Assessment of Copy Number Alterations Uncovers Recurrent AIFM3 and DLK1 Copy Gain in Medullary Thyroid Carcinoma
por: Araujo, Aline Neves, et al.
Publicado: (2021)

Trop-2 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

ACTN3 Genotype in Professional Sport Climbers
por: Ginszt, Michał, et al.
Publicado: (2018)

Novel ACTN1 variants in cases of thrombocytopenia
por: Vincenot, Anne, et al.
Publicado: (2019)

Role of ACTN4 in Tumorigenesis, Metastasis, and EMT
por: Tentler, Dmitri, et al.
Publicado: (2019)

Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder
por: Lee, Dong Hyeon, et al.
Publicado: (2018)

c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia
por: Kübler, Kirsten, et al.
Publicado: (2014)

ErbB2 copy number gain is associated with adverse outcome in canine mammary carcinoma
por: SAKAI, Kosei, et al.
Publicado: (2021)

Characterization and clinical relevance of PDGFRA pathway copy number variation gains across human cancers
por: Liu, Lizhu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b8rcs75m0s71dl4mtpn8emj5pq